Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31257

1.

Comparison of Ivor-Lewis versus Sweet procedure for middle and lower thoracic esophageal squamous cell carcinoma: A STROBE compliant study.

Wang J, Wei N, Jiang N, Lu Y, Zhang X.

Medicine (Baltimore). 2019 Feb;98(6):e14416. doi: 10.1097/MD.0000000000014416.

2.

Response.

Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, Iyer PG.

Gastrointest Endosc. 2019 Feb;89(2):444. doi: 10.1016/j.gie.2018.10.006. No abstract available.

PMID:
30665539
3.

Screening for esophageal squamous cell carcinoma: insight from experience with Barrett's esophagus.

Yang F, Ma D, Li Z.

Gastrointest Endosc. 2019 Feb;89(2):443-444.e1. doi: 10.1016/j.gie.2018.09.019. No abstract available.

PMID:
30665537
5.

Mutations differ in normal and cancer cells of the oesophagus.

Ciccarelli FD.

Nature. 2019 Jan;565(7739):301-303. doi: 10.1038/d41586-018-07737-8. No abstract available.

PMID:
30643303
6.

Skeletal muscle mass as a predictor of the response to neo-adjuvant chemotherapy in locally advanced esophageal cancer.

Ota T, Ishikawa T, Endo Y, Matsumura S, Yoshida J, Yasuda T, Okayama T, Inoue K, Dohi O, Yoshida N, Sakamoto N, Kamada K, Uchiyama K, Takagi T, Konishi H, Konishi H, Shiozaki A, Fujiwara H, Kishimoto M, Naito Y, Itoh Y.

Med Oncol. 2019 Jan 2;36(2):15. doi: 10.1007/s12032-018-1242-0.

PMID:
30600347
7.

Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.

Nishiumi S, Fujigaki S, Kobayashi T, Kojima T, Ito Y, Daiko H, Kato K, Shoji H, Kodama Y, Honda K, Yoshida M.

Anticancer Res. 2019 Jan;39(1):519-526. doi: 10.21873/anticanres.13143.

PMID:
30591504
9.

Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer.

Nomoto D, Yoshida N, Akiyama T, Kiyozumi Y, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Iwagami S, Baba Y, Miyamoto Y, Baba H.

Anticancer Res. 2019 Jan;39(1):471-475. doi: 10.21873/anticanres.13136.

PMID:
30591497
10.

Scheduled Intravenous Acetaminophen for Postoperative Management of Patients Who Had Thoracoscopic Esophagectomy for Esophageal Cancer.

Kitagawa H, Namikawa T, Iwabu J, Uemura S, Munekage M, Tsuda S, Yokota K, Kobayashi M, Hanazaki K.

Anticancer Res. 2019 Jan;39(1):467-470. doi: 10.21873/anticanres.13135.

PMID:
30591496
11.

Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer.

Matsunaga T, Miyata H, Sugimura K, Motoori M, Asukai K, Yanagimoto Y, Takahashi Y, Tomokuni A, Yamamoto K, Akita H, Nishimura J, Wada H, Takahashi H, Yasui M, Omori T, Oue M, Yano M.

Anticancer Res. 2019 Jan;39(1):449-458. doi: 10.21873/anticanres.13133.

PMID:
30591494
12.
13.

Feasibility and strategy of common hepatic artery lymph node dissection in thoracolaparoscopic esophagectomy for thoracic esophageal squamous cell cancer.

Han ZY, Kang MQ, Lin JB, Chen SC, Chen S, Yu SB.

Medicine (Baltimore). 2018 Dec;97(51):e13587. doi: 10.1097/MD.0000000000013587.

14.

Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome.

Ajayi TA, Cantrell S, Spann A, Garman KS.

PLoS Pathog. 2018 Dec 20;14(12):e1007384. doi: 10.1371/journal.ppat.1007384. eCollection 2018 Dec. No abstract available.

15.

Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.

Xue LY, Qin XM, Liu Y, Liang J, Lin H, Xue XM, Zou SM, Zhang MY, Zhang BH, Hui ZG, Zhao ZT, Ren LQ, Zhang YM, Liu XY, Yuan YL, Ying JM, Gao SG, Song YM, Wang GQ, Dawsey SM, Lu N.

World J Gastroenterol. 2018 Dec 7;24(45):5154-5166. doi: 10.3748/wjg.v24.i45.5154.

16.

"Sentinel lymph node imaging with sequential SPECT/CT lymphoscintigraphy before and after neoadjuvant chemoradiotherapy in patients with cancer of the oesophagus or gastro-oesophageal junction - a pilot study".

Gabrielson S, Tsai JA, Celebioglu F, Nilsson M, Rouvelas I, Lindblad M, Bjäreback A, Tomson A, Axelsson R.

Cancer Imaging. 2018 Dec 18;18(1):53. doi: 10.1186/s40644-018-0185-1.

17.
18.

Palliation of dysphagia.

van der Bogt RD, Vermeulen BD, Reijm AN, Siersema PD, Spaander MCW.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:97-103. doi: 10.1016/j.bpg.2018.11.010. Epub 2018 Nov 22. Review.

PMID:
30551864
19.

Molecular pathways in the development and treatment of oesophageal cancer.

Walker RC, Underwood TJ.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:9-15. doi: 10.1016/j.bpg.2018.11.013. Epub 2018 Nov 23. Review.

PMID:
30551862
20.

The management of mid & proximal oesophageal squamous cell carcinoma.

Wong I, Law S.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:85-90. doi: 10.1016/j.bpg.2018.11.012. Epub 2018 Nov 30. Review.

PMID:
30551861

Supplemental Content

Loading ...
Support Center